Patent · US Active

Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors

US11584763B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

HiberCell, Inc. · US

Inventors

Johan Lindström · Huddinge, SE
Lars Boukharta Persson · Uppsala, SE
Jenny Viklund · Kungshättan, SE
Rickard Forsblom · Tullinge, SE
Tobias Ginman · Tullinge, SE
Edward A. Kesicki · Bothell, US
Eugene Richard Hickey · Danbury, US
Markus Dahlgren · Stratford, US
Aleksey I. Gerasyuto · Flemington, US

Key dates

Filing date	Dec 21, 2018
Grant date	Feb 21, 2023
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0053
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: where A1, A2, G, R1, R2, R3, R4, and W are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.